Received Feb 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 93KK4 | — |
An 84 years old female patient received a dose of Shingrix after the vaccine had a temperature excursion at an unknown temperature for 72 hours.; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a 84-year-old female patient who received Herpes zoster (Shingrix) (batch number 93KK4, expiry date 31-JAN-2027) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incorrect storage of drug (Verbatim: An 84 years old female patient received a dose of Shingrix after the vaccine had a temperature excursion at an unknown temperature for 72 hours.). The outcome of the incorrect storage of drug was unknown. Additional Information: GSK Receipt Date: 19-FEB-2025 A Pharmacy Manager called to report that they administered Shingrix to a patient after a temperature excursion which led to product storage error. The Shingrix vaccine was exposed to an unknown temperature for 72 hours.